leading to intraocular inflammation has to be generated outside of the eye, and we postulate a cross-reactive nonocular antigen as the activator of T cells (antigenic mimicry). T cells activated to such a mimotope are then able to enter the eye because activated T cells can pass the blood-retina barrier. In the eye they are reactivated by cross-reactive retinal antigen. There is one exception to this mechanism of disease induction, which is sympathetic ophthalmia. Here, the injury to one eye allows the entry of immune cells to ocular tissue and a direct generation of an ocular antigen-specific immune response.
We could describe two mimotopes of retinal peptide PDSAg, peptides derived from environmental antigens. One peptide, Cas, covers AA 73-84 of bovine milk ␣ s2-casein and is a typical nutritional antigen, the other, Rota, is derived from the outer capsid protein (AA 591-601) from gastroenteritis-causing rotavirus [3] . Both peptides induce uveitis after immunization with complete Freund's adjuvant (CFA), with a lower incidence but the same disease severity as with PDSAg. T cell lines specific for Rota and Cas are also pathogenic; moreover, they show crossreactivity to PDSAg in vitro. Not only Cas peptide but also ␣ s2-casein protein is able to induce uveitis in Lewis rats. The disease is indistinguishable from PDSAg-induced EAU with respect to clinical course and histology. Since nutritional antigens are normally applied to the gastrointestinal mucosa and not subcutaneously, we also tried to induce EAU by feeding the antigens together with native cholera toxin, which is a Th1-shifting gastrointestinal adjuvant in rats. Only casein protein, but none of the peptides or S-Ag was able to induce EAU by the oral route, indicating that a gastrointestinal immune response to cross-reactive antigens might be a way to induce ocular autoimmune disease. Uveitis patients showed significantly higher immune responses (T cells, antibodies) to retinal S-Ag, peptide and the mimotopes than healthy controls.
Intraocular Reactivation of Cross-Reactive T Cells
To follow the migration of autoreactive T cells, we injected antigen-activated, green-fluorescent-protein (GFP)-transduced R14-or ovalbumin (OVA)-specific control T cells intravenously into naive rats. The migration of fluorescent T cells was observed by daily intravital fluorescence microscopy of the iris [4] . The first GFP+ T cells, irrespective of their specificity for autoantigen or OVA, extravasated and entered the iris tissue within 30 min after injection. The number of GFP+ cells of either specificity gradually increased within the first 3 days. After 3 days the number of OVA-specific GFP+ T cells decreased, whereas R14-specific T cells increased, accompanied by an infiltration of GFP-inflammatory cells. At this time point the clinical disease started, with ophthalmoscopically visible infiltration of leucocytes. The time between the immigration of the first autoreactive T cells and the recruitment of inflammatory cells is probably the prodromal state, which patients with anterior uveitis sometimes experience as an 'organ feeling' or pain preceding a clinically visible relapse of uveitis.
The invasion of ocular tissue by numerous OVA-specific T cells underlines the fact that activated T cells of any specificity can overcome the blood-retina barrier and enter the eye, but without causing destruction -unless they find their specific or cross-reactive antigen, and get reactivated. Staining for surface markers of T cell activation revealed that R14-specific GFP+ T cells are reactivated in the eye, but neither in lymphoid organs nor in blood, whereas OVA-specific GFP+ T cells experience no reactivation. To prove that antigen-specific reactivation is sufficient to induce uveitis, we injected OVA into the anterior chamber after the adoptive transfer of OVA-specific T cell lines. In this case we induced 'immunogenic uveitis' and also observed upregulation of activation markers on OVA-specific T cells isolated from the eye. Therefore, reactivated T cells can recruit inflammatory cells that cause destruction of ocular tissues.
Differences between EAU Induced with S-Ag Peptide PDSAg or IRBP Peptide R14
EAU in Lewis rats was regarded as an acute, monophasic disease, until Shao et al. [5] described relapsing disease after adoptive transfer of T cell lines specific for a peptide from IRBP (AA 1177-1191), which is an N-terminally truncated form of IRBP peptide R14.
We observed relapses of EAU after immunization of rats with peptide R14 in CFA and could reinduce EAU after prior disease induction with R14-CFA or adoptive transfer or R14-specific T cell lines but not after primary PDSAg-mediated disease [6] . T cell lines specific for R14 or PDSAg are both of the Th1 type; however, in culture supernatants of R14-specific T cells we find higher concentrations of cytokines than in supernatants of PDSAgspecific T cells, independent of the proliferation of the respective T cells [7] .
R14-and PDSAg-mediated EAU is furthermore differently regulated with respect to chemokines. Disease induced by adoptive transfer of PDSAg-specific T cells was completely blocked by injection of N-terminally methionylated RANTES, a CCR1/CCR5 receptor antagonist, which had no effect on EAU induced by adoptive transfer of R14-specific T cells [7] . We could furthermore observe differences in the preferential site of infiltration of cells in R14-and PDSAg-induced diseases: while in PDSAg-mediated EAU cells mainly invade the retina from the choroid by destroying the retinal pigment epithelium, the cells in R14-mediated EAU immigrate mainly from the retinal vessels, destroying photoreceptors but not the retinal pigment epithelium.
Taken together, these data suggest that we have two antigen-dependent model diseases for uveitis in the same strain of rats.
Oral Tolerance Induction: Antigen-Specific Suppression as a Therapy of Uveitis
Highly specific tolerance induction to only hit the autoaggressive immune response without impeding the general immune defense is a desired therapeutic approach for autoimmune diseases ( fig. 1 ) . Oral tolerance is a way to induce antigen-specific tolerance by feeding the respective (auto)antigen. In the rat model, feeding of S-Ag or the peptide PDSAg can suppress S-Ag-induced EAU, and feeding IRBP suppresses IRBP-induced uveitis. We described a peptide derived from the sequence of HLA-B antigens that is called B27PD, although it is not only B27-specific. This peptide shares AA sequence homologies with peptide PDSAg and can serve as oral tolerogen to suppress EAU induced with 
